-
1.Methods of treatment of amyloidosis using spirocyclohexane aspartyl-protease inhibitors 审中-公开
标题翻译: 使用螺环己烷天冬氨酰蛋白酶抑制剂治疗淀粉样变性的方法公开(公告)号:US20060014790A1
公开(公告)日:2006-01-19
申请号:US11038790
申请日:2005-01-21
申请人: Varghese John , Roy Hom , Jennifer Sealy , Jose Aquino , Gary Probst , Jay Tung , Lawrence Fang
发明人: Varghese John , Roy Hom , Jennifer Sealy , Jose Aquino , Gary Probst , Jay Tung , Lawrence Fang
IPC分类号: A61K31/445 , A61K31/38 , A61K31/165 , A61K31/381
CPC分类号: A61K31/38 , A61K31/165 , A61K31/381 , A61K31/445
摘要: The invention relates to acetyl 2-hydroxy-1,3-diaminospirocyclohexanes and derivatives thereof that are useful in treating diseases, disorders, and conditions associated with amyloidosis. Amyloidosis refers to a collection of diseases, disorders, and conditions associated with abnormal deposition of A-beta protein.
摘要翻译: 本发明涉及可用于治疗与淀粉样变性相关的疾病,病症和病症的乙酰基2-羟基-1,3-二氨基螺环己烷及其衍生物。 淀粉样变性是指与A-β蛋白异常沉积相关的疾病,病症和病症的集合。
-
2.
公开(公告)号:US20060128715A1
公开(公告)日:2006-06-15
申请号:US11177348
申请日:2005-07-11
申请人: Jennifer Sealy , Roy Hom , Varghese John , Gary Probst , Jay Tung
发明人: Jennifer Sealy , Roy Hom , Varghese John , Gary Probst , Jay Tung
IPC分类号: A61K31/4965 , A61K31/513 , A61K31/50 , A61K31/381 , A61K31/416 , A61K31/4015 , A61K31/44 , A61K31/165
CPC分类号: C07D239/74 , C07C233/36 , C07C237/18 , C07C251/44 , C07C251/54 , C07C251/58 , C07C251/84 , C07C255/31 , C07C255/61 , C07C2601/14 , C07D207/335 , C07D213/40 , C07D213/53 , C07D231/12 , C07D231/56 , C07D239/18 , C07D239/26 , C07D261/20 , C07D307/52 , C07D317/72 , C07D333/22 , C07D403/10 , C07D405/10 , C07D409/04 , C07D409/10
摘要: The invention relates to novel compounds and methods of treating diseases, disorders, and conditions associated with amyloidosis. Amyloidosis refers to a collection of diseases, disorders, and conditions associated with abnormal deposition of A-beta protein.
摘要翻译: 本发明涉及治疗与淀粉样变性相关的疾病,病症和病症的新化合物和方法。 淀粉样变性是指与A-β蛋白异常沉积相关的疾病,病症和病症的集合。
-
3.Methods of treatment of amyloidosis using bi-cyclic aspartyl protease inhibitors 审中-公开
标题翻译: 使用双环天冬氨酰蛋白酶抑制剂治疗淀粉样变性的方法公开(公告)号:US20050239832A1
公开(公告)日:2005-10-27
申请号:US11074828
申请日:2005-03-09
申请人: Varghese John , Michel Maillard , Lawrence Fang , John Tucker , Louis Brogley , Jose Aquino , Simeon Bowers , Gary Probst , Jay Tung
发明人: Varghese John , Michel Maillard , Lawrence Fang , John Tucker , Louis Brogley , Jose Aquino , Simeon Bowers , Gary Probst , Jay Tung
IPC分类号: A61K31/137 , A61K31/35 , A61K31/381 , A61K31/445 , A61K31/47
CPC分类号: A61K31/137 , A61K31/35 , A61K31/381 , A61K31/445 , A61K31/47
摘要: The invention relates to novel compounds and methods of treating diseases, disorders, and conditions associated with amyloidosis. Amyloidosis refers to a collection of diseases, disorders, and conditions associated with abnormal deposition of A-beta protein.
摘要翻译: 本发明涉及治疗与淀粉样变性相关的疾病,病症和病症的新化合物和方法。 淀粉样变性是指与A-β蛋白异常沉积相关的疾病,病症和病症的集合。
-
4.Substituted urea and carbamate, phenacyl-2-hydroxy-3-diaminoalkane, and benzamide-2-hydroxy-3-diaminoalkane aspartyl-protease inhibitors 审中-公开
标题翻译: 取代的脲和氨基甲酸酯,苯甲酰甲基-2-羟基-3-二氨基烷烃和苯甲酰胺-2-羟基-3-二氨基烷烃天冬氨酰蛋白酶抑制剂公开(公告)号:US20050261273A1
公开(公告)日:2005-11-24
申请号:US11075292
申请日:2005-03-09
申请人: Varghese John , Michel Maillard , John Tucker , Jose Aquino , Roy Hom , Jay Tung , Darren Dressen , Neerav Shah , R. Neitz
发明人: Varghese John , Michel Maillard , John Tucker , Jose Aquino , Roy Hom , Jay Tung , Darren Dressen , Neerav Shah , R. Neitz
IPC分类号: A61K31/16 , A61K31/40 , A61K31/445 , A61K31/496 , A61K31/5377 , A61K31/541 , A61K31/553 , C07C215/28 , C07C229/42 , C07C229/60 , C07C233/40 , C07C235/10 , C07C235/42 , C07C235/74 , C07C235/82 , C07C237/14 , C07C237/30 , C07C239/16 , C07C255/34 , C07C275/06 , C07C275/14 , C07C275/26 , C07C275/28 , C07C311/03 , C07C311/05 , C07C311/07 , C07C311/08 , C07C323/30 , C07C323/59 , C07C327/46 , C07D205/04 , C07D207/16 , C07D207/28 , C07D209/12 , C07D209/18 , C07D211/56 , C07D211/58 , C07D211/94 , C07D213/56 , C07D213/81 , C07D213/82 , C07D231/14 , C07D233/30 , C07D233/46 , C07D233/54 , C07D233/76 , C07D233/90 , C07D239/26 , C07D241/24 , C07D257/04 , C07D261/08 , C07D261/10 , C07D261/14 , C07D261/18 , C07D277/14 , C07D277/28 , C07D277/56 , C07D307/00 , C07D307/24 , C07D307/54 , C07D307/68 , C07D309/14 , C07D311/96 , C07D317/72 , C07D333/20 , C07D333/24 , C07D333/28 , C07D333/38 , C07D335/06 , C07D405/10 , C07D407/12 , C07F9/40
CPC分类号: C07D335/06 , A61K31/16 , C07C215/28 , C07C229/42 , C07C229/60 , C07C233/36 , C07C233/40 , C07C235/10 , C07C235/74 , C07C235/82 , C07C237/30 , C07C239/16 , C07C255/34 , C07C271/20 , C07C271/22 , C07C275/14 , C07C275/26 , C07C311/03 , C07C311/05 , C07C311/07 , C07C311/08 , C07C323/30 , C07C323/59 , C07C327/46 , C07C2601/02 , C07C2601/10 , C07C2601/14 , C07C2602/10 , C07C2603/74 , C07D205/04 , C07D207/16 , C07D207/28 , C07D209/12 , C07D209/18 , C07D209/42 , C07D211/56 , C07D211/58 , C07D211/94 , C07D213/56 , C07D213/81 , C07D213/82 , C07D231/14 , C07D233/30 , C07D233/46 , C07D233/58 , C07D233/64 , C07D233/76 , C07D233/90 , C07D239/26 , C07D241/24 , C07D257/04 , C07D261/08 , C07D261/10 , C07D261/14 , C07D261/18 , C07D277/14 , C07D277/24 , C07D277/28 , C07D277/56 , C07D307/00 , C07D307/24 , C07D307/54 , C07D307/68 , C07D309/14 , C07D311/96 , C07D317/72 , C07D333/18 , C07D333/20 , C07D333/24 , C07D333/28 , C07D333/38 , C07D405/10 , C07D407/12 , C07F9/4006
摘要: The invention relates to acetyl 2-hydroxy-1,3-diaminospirocyclohexanes and derivatives thereof that are useful in treating at least one disease, disorder, and condition associated with amyloidosis. Amyloidosis refers to a collection of diseases, disorders, and condition associated with abnormal deposition of A-beta protein.
摘要翻译: 本发明涉及可用于治疗与淀粉样变性相关的至少一种疾病,病症和状况的乙酰基2-羟基-1,3-二氨基螺环己烷及其衍生物。 淀粉样变性是指与A-β蛋白异常沉积相关的疾病,病症和病症的集合。
-
5.
公开(公告)号:US20070213316A1
公开(公告)日:2007-09-13
申请号:US11636903
申请日:2006-12-11
申请人: Varghese John , Michel Maillard , Barbara Jagodzinska , James Beck , Andrea Gailunas , John Freskos , John Mickelson , Lakshman Samala , Jennifer Sealy , Ruth TenBrink , Lawrence Fang , Roy Hom
发明人: Varghese John , Michel Maillard , Barbara Jagodzinska , James Beck , Andrea Gailunas , John Freskos , John Mickelson , Lakshman Samala , Jennifer Sealy , Ruth TenBrink , Lawrence Fang , Roy Hom
IPC分类号: A61K31/553 , A61K31/554 , A61K31/55 , A61K31/54 , A61K31/5377 , A61K31/275 , A61K31/4965
CPC分类号: C07D263/32 , C07C233/36 , C07C233/40 , C07C233/58 , C07C233/78 , C07C235/20 , C07C235/50 , C07C235/74 , C07C237/04 , C07C237/06 , C07C237/08 , C07C237/22 , C07C237/42 , C07C251/38 , C07C255/58 , C07C271/28 , C07C271/44 , C07C311/08 , C07C311/16 , C07C311/17 , C07C311/18 , C07C311/19 , C07C311/20 , C07C311/21 , C07C311/37 , C07C317/46 , C07C317/50 , C07C323/60 , C07C323/62 , C07C323/65 , C07C2601/02 , C07C2601/08 , C07C2601/14 , C07D207/267 , C07D207/27 , C07D209/42 , C07D211/58 , C07D211/60 , C07D211/96 , C07D213/71 , C07D213/80 , C07D213/82 , C07D213/85 , C07D215/36 , C07D215/42 , C07D215/48 , C07D215/56 , C07D217/22 , C07D231/14 , C07D231/38 , C07D233/84 , C07D233/90 , C07D237/14 , C07D239/28 , C07D239/42 , C07D239/48 , C07D241/20 , C07D241/24 , C07D241/44 , C07D243/08 , C07D249/06 , C07D249/10 , C07D251/46 , C07D251/54 , C07D257/04 , C07D257/06 , C07D261/08 , C07D261/14 , C07D261/18 , C07D263/34 , C07D263/48 , C07D263/54 , C07D263/58 , C07D265/36 , C07D271/08 , C07D271/12 , C07D275/06 , C07D277/30 , C07D277/36 , C07D277/56 , C07D277/68 , C07D277/82 , C07D279/16 , C07D285/06 , C07D285/10 , C07D285/135 , C07D295/155 , C07D295/185 , C07D295/192 , C07D295/26 , C07D307/20 , C07D307/46 , C07D307/68 , C07D307/84 , C07D307/86 , C07D307/91 , C07D311/04 , C07D333/22 , C07D333/32 , C07D333/34 , C07D333/38 , C07D333/62 , C07D333/68 , C07D335/06 , C07D401/04 , C07D405/12 , C07D409/04 , C07D411/12 , C07D413/04 , C07D413/12 , C07D417/04 , C07D417/12 , C07D471/04 , C07D473/06 , C07D473/08 , C07D473/16 , C07D487/04 , C07D495/04
摘要: Disclosed are compounds of the formula wherein the variables RN, RC, R1, R25, R2, and R3 are as defined herein. These compounds have activity as inhibitors of beta-secretase and are therefore useful in treating a variety of discorders such as Alzheimer's Disease.
摘要翻译: 公开了下式的化合物,其中R 1,R 2,R 1,R 2,R 2,R 2, < 2>和< 3>如本文所定义。 这些化合物具有作为β-分泌酶抑制剂的活性,因此可用于治疗诸如阿尔茨海默氏病之类的各种紊乱。
-
公开(公告)号:US07176242B2
公开(公告)日:2007-02-13
申请号:US10291318
申请日:2002-11-08
申请人: Varghese John , Michel Maillard , Barbara Jagodzinska , James Beck , Andrea Gailunas , John Freskos , John Mickelson , Lakshman Samala , Jennifer Sealy , Ruth TenBrink , Lawrence Fang , Roy Hom
发明人: Varghese John , Michel Maillard , Barbara Jagodzinska , James Beck , Andrea Gailunas , John Freskos , John Mickelson , Lakshman Samala , Jennifer Sealy , Ruth TenBrink , Lawrence Fang , Roy Hom
IPC分类号: A61K31/133 , C07C217/00
CPC分类号: C07D263/32 , C07C233/36 , C07C233/40 , C07C233/58 , C07C233/78 , C07C235/20 , C07C235/50 , C07C235/74 , C07C237/04 , C07C237/06 , C07C237/08 , C07C237/22 , C07C237/42 , C07C251/38 , C07C255/58 , C07C271/28 , C07C271/44 , C07C311/08 , C07C311/16 , C07C311/17 , C07C311/18 , C07C311/19 , C07C311/20 , C07C311/21 , C07C311/37 , C07C317/46 , C07C317/50 , C07C323/60 , C07C323/62 , C07C323/65 , C07C2601/02 , C07C2601/08 , C07C2601/14 , C07D207/267 , C07D207/27 , C07D209/42 , C07D211/58 , C07D211/60 , C07D211/96 , C07D213/71 , C07D213/80 , C07D213/82 , C07D213/85 , C07D215/36 , C07D215/42 , C07D215/48 , C07D215/56 , C07D217/22 , C07D231/14 , C07D231/38 , C07D233/84 , C07D233/90 , C07D237/14 , C07D239/28 , C07D239/42 , C07D239/48 , C07D241/20 , C07D241/24 , C07D241/44 , C07D243/08 , C07D249/06 , C07D249/10 , C07D251/46 , C07D251/54 , C07D257/04 , C07D257/06 , C07D261/08 , C07D261/14 , C07D261/18 , C07D263/34 , C07D263/48 , C07D263/54 , C07D263/58 , C07D265/36 , C07D271/08 , C07D271/12 , C07D275/06 , C07D277/30 , C07D277/36 , C07D277/56 , C07D277/68 , C07D277/82 , C07D279/16 , C07D285/06 , C07D285/10 , C07D285/135 , C07D295/155 , C07D295/185 , C07D295/192 , C07D295/26 , C07D307/20 , C07D307/46 , C07D307/68 , C07D307/84 , C07D307/86 , C07D307/91 , C07D311/04 , C07D333/22 , C07D333/32 , C07D333/34 , C07D333/38 , C07D333/62 , C07D333/68 , C07D335/06 , C07D401/04 , C07D405/12 , C07D409/04 , C07D411/12 , C07D413/04 , C07D413/12 , C07D417/04 , C07D417/12 , C07D471/04 , C07D473/06 , C07D473/08 , C07D473/16 , C07D487/04 , C07D495/04
摘要: Disclosed are compounds of the formula wherein the variables RN, RC, R1, R25, R2, and R3 are as defined herein. These compounds have activity as inhibitors of beta-secretase and are therefore useful in treating a variety of discorders such as Alzheimer's Disease.
-
7.OXIME DERIVATIVE SUBSTITUTED HYDROXYETHYLAMINE ASPARTYL PROTEASE INHIBITORS 审中-公开
标题翻译: OXIME衍生的取代羟基乙酰胺ASPARTYL蛋白酶抑制剂公开(公告)号:US20090042961A1
公开(公告)日:2009-02-12
申请号:US12117094
申请日:2008-05-08
申请人: Varghese John , Michel Maillard , Barbara Jagodzinska , Jose Aquino , Gary Probst , Jay Tung
发明人: Varghese John , Michel Maillard , Barbara Jagodzinska , Jose Aquino , Gary Probst , Jay Tung
IPC分类号: A61K31/165 , A61P43/00 , C07D257/04 , C07C233/36 , C07C243/20 , C07D405/10 , A61K31/4155 , A61K31/41 , C07D231/12 , A61K31/415 , C07D231/54 , A61K31/416
CPC分类号: C07D285/08 , C07C233/36 , C07C237/20 , C07C251/44 , C07C251/54 , C07C251/84 , C07C255/42 , C07C255/58 , C07C2601/04 , C07C2601/14 , C07D213/40 , C07D231/12 , C07D231/56 , C07D233/64 , C07D257/04 , C07D261/20 , C07D271/10 , C07D335/06 , C07D405/10
摘要: The invention relates to novel compounds and methods of treating diseases, disorders, and conditions associated with amyloidosis. Amyloidosis refers to a collection of diseases, disorders, and conditions associated with abnormal deposition of A-beta protein.
摘要翻译: 本发明涉及治疗与淀粉样变性相关的疾病,病症和病症的新化合物和方法。 淀粉样变性是指与A-β蛋白异常沉积相关的疾病,病症和病症的集合。
-
8.Oxime derivative substituted hydroxyethylamine aspartyl protease inhibitors 失效
标题翻译: 肟衍生物取代的羟乙基胺天冬氨酰蛋白酶抑制剂公开(公告)号:US20070149584A9
公开(公告)日:2007-06-28
申请号:US11177324
申请日:2005-07-11
申请人: Varghese John , Michel Maillard , Barbara Jagodzinska , Jose Aquino , Gary Probst , Jay Tung
发明人: Varghese John , Michel Maillard , Barbara Jagodzinska , Jose Aquino , Gary Probst , Jay Tung
IPC分类号: A61K31/42 , A61K31/416 , A61K31/165
CPC分类号: C07D285/08 , C07C233/36 , C07C237/20 , C07C251/44 , C07C251/54 , C07C251/84 , C07C255/42 , C07C255/58 , C07C2601/04 , C07C2601/14 , C07D213/40 , C07D231/12 , C07D231/56 , C07D233/64 , C07D257/04 , C07D261/20 , C07D271/10 , C07D335/06 , C07D405/10
摘要: The invention relates to novel compounds and methods of treating diseases, disorders, and conditions associated with amyloidosis. Amyloidosis refers to a collection of diseases, disorders, and conditions associated with abnormal deposition of A-beta protein.
摘要翻译: 本发明涉及治疗与淀粉样变性相关的疾病,病症和病症的新化合物和方法。 淀粉样变性是指与A-β蛋白异常沉积相关的疾病,病症和病症的集合。
-
9.Oxime derivative substituted hydroxyethylamine aspartyl protease inhibitors 失效
标题翻译: 肟衍生物取代的羟乙基胺天冬氨酰蛋白酶抑制剂公开(公告)号:US20060135581A1
公开(公告)日:2006-06-22
申请号:US11177324
申请日:2005-11-17
申请人: Varghese John , Michel Maillard , Barbara Jagodzinska , Jose Aquino , Gary Probst , Jay Tung
发明人: Varghese John , Michel Maillard , Barbara Jagodzinska , Jose Aquino , Gary Probst , Jay Tung
IPC分类号: A61K31/42 , A61K31/416 , A61K31/165
CPC分类号: C07D285/08 , C07C233/36 , C07C237/20 , C07C251/44 , C07C251/54 , C07C251/84 , C07C255/42 , C07C255/58 , C07C2601/04 , C07C2601/14 , C07D213/40 , C07D231/12 , C07D231/56 , C07D233/64 , C07D257/04 , C07D261/20 , C07D271/10 , C07D335/06 , C07D405/10
摘要: The invention relates to novel compounds and methods of treating diseases, disorders, and conditions associated with amyloidosis. Amyloidosis refers to a collection of diseases, disorders, and conditions associated with abnormal deposition of A-beta protein.
摘要翻译: 本发明涉及治疗与淀粉样变性相关的疾病,病症和病症的新化合物和方法。 淀粉样变性是指与A-β蛋白异常沉积相关的疾病,病症和病症的集合。
-
公开(公告)号:US20050239836A1
公开(公告)日:2005-10-27
申请号:US11075312
申请日:2005-03-09
申请人: Varghese John , Michel Maillard , John Tucker , Jose Aquino , Barbara Jagodzinska , Louis Brogley , Jay Tung , Simeon Bowers , Darren Dressen , Gary Probst , Neerav Shah
发明人: Varghese John , Michel Maillard , John Tucker , Jose Aquino , Barbara Jagodzinska , Louis Brogley , Jay Tung , Simeon Bowers , Darren Dressen , Gary Probst , Neerav Shah
IPC分类号: A61K31/382 , A61K31/453 , C07D207/32 , C07D207/325 , C07D233/54 , C07D257/04 , C07D335/06 , C07D403/12 , C07D405/12 , C07D419/12 , C07D49/02
CPC分类号: C07D419/12 , C07C215/28 , C07C215/50 , C07C217/30 , C07C217/34 , C07C217/48 , C07C217/52 , C07C217/58 , C07C225/06 , C07C225/20 , C07C229/16 , C07C229/42 , C07C229/60 , C07C233/43 , C07C237/20 , C07C237/30 , C07C271/12 , C07C311/24 , C07C317/28 , C07C323/25 , C07C323/30 , C07C323/32 , C07C2601/02 , C07C2601/14 , C07C2602/04 , C07C2602/10 , C07C2602/42 , C07C2603/18 , C07C2603/74 , C07D207/323 , C07D207/325 , C07D213/38 , C07D215/42 , C07D231/12 , C07D231/38 , C07D233/54 , C07D233/64 , C07D233/88 , C07D239/42 , C07D239/48 , C07D249/04 , C07D249/06 , C07D249/14 , C07D257/04 , C07D263/34 , C07D271/113 , C07D275/02 , C07D277/42 , C07D285/08 , C07D285/10 , C07D285/135 , C07D307/52 , C07D309/14 , C07D311/74 , C07D333/36 , C07D335/06 , C07D401/12 , C07D403/12 , C07D405/12 , C07D409/12 , C07D413/04 , C07D413/12 , C07D417/12 , C07D495/04
摘要: The invention relates to novel compounds and also to methods of treating at least one disease, disorder, or condition associated with amyloidosis using such compounds. Amyloidosis refers to a collection of diseases, disorders, and conditions associated with abnormal deposition of A-beta protein.
-
-
-
-
-
-
-
-
-